111 related articles for article (PubMed ID: 34077000)
1. Prognostic and immunomodulatory effects of PIM1 in colorectal carcinoma.
Zhou Y; Zhou Y; Liu S; Wang J; Ji R; Yan X
J BUON; 2021; 26(2):513-520. PubMed ID: 34077000
[TBL] [Abstract][Full Text] [Related]
2. TAB3 upregulates PIM1 expression by directly activating the TAK1-STAT3 complex to promote colorectal cancer growth.
Li Q; Chen L; Luo C; ChenYan ; Ge J; Zhu Z; Wang K; Yu X; Lei J; Liu T; Peng X; Liu X; Yuan R
Exp Cell Res; 2020 Jun; 391(1):111975. PubMed ID: 32229191
[TBL] [Abstract][Full Text] [Related]
3. Pim1 supports human colorectal cancer growth during glucose deprivation by enhancing the Warburg effect.
Zhang M; Liu T; Sun H; Weng W; Zhang Q; Liu C; Han Y; Sheng W
Cancer Sci; 2018 May; 109(5):1468-1479. PubMed ID: 29516572
[TBL] [Abstract][Full Text] [Related]
4. Integrated Analysis of Expression and Prognostic Values of Acyl-CoA Dehydrogenase short-chain in Colorectal Cancer.
Wu Q; Yan T; Chen Y; Chang J; Jiang Y; Zhu D; Wei Y
Int J Med Sci; 2021; 18(16):3631-3643. PubMed ID: 34790035
[No Abstract] [Full Text] [Related]
5. Prognostic and immune regulating roles of YIF1B in Pan-Cancer: a potential target for both survival and therapy response evaluation.
Liu J; Chen Z; Zhao P; Li W
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32648580
[TBL] [Abstract][Full Text] [Related]
6. Grid2 interacting protein is a potential biomarker related to immune infiltration in colorectal cancer.
Zhao J; Quan J; Chen W; Xie X
Eur J Med Res; 2023 Nov; 28(1):511. PubMed ID: 37964339
[TBL] [Abstract][Full Text] [Related]
7. Hispidulin suppresses cell growth and metastasis by targeting PIM1 through JAK2/STAT3 signaling in colorectal cancer.
Liu K; Gao H; Wang Q; Wang L; Zhang B; Han Z; Chen X; Han M; Gao M
Cancer Sci; 2018 May; 109(5):1369-1381. PubMed ID: 29575334
[TBL] [Abstract][Full Text] [Related]
8. A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer.
Xiao J; Li W; Huang Y; Huang M; Li S; Zhai X; Zhao J; Gao C; Xie W; Qin H; Cai S; Bai Y; Lan P; Zou Y
BMC Cancer; 2021 Mar; 21(1):282. PubMed ID: 33726687
[TBL] [Abstract][Full Text] [Related]
9. PIM kinases are essential for chronic lymphocytic leukemia cell survival (PIM2/3) and CXCR4-mediated microenvironmental interactions (PIM1).
Decker S; Finter J; Forde AJ; Kissel S; Schwaller J; Mack TS; Kuhn A; Gray N; Follo M; Jumaa H; Burger M; Zirlik K; Pfeifer D; Miduturu CV; Eibel H; Veelken H; Dierks C
Mol Cancer Ther; 2014 May; 13(5):1231-45. PubMed ID: 24659821
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value and immunological role of PDCD1 gene in pan-cancer.
Miao Y; Wang J; Li Q; Quan W; Wang Y; Li C; Wu J; Mi D
Int Immunopharmacol; 2020 Dec; 89(Pt B):107080. PubMed ID: 33069926
[TBL] [Abstract][Full Text] [Related]
11. Genomic signature of MTOR could be an immunogenicity marker in human colorectal cancer.
Wang C; Aikemu B; Shao Y; Zhang S; Yang G; Hong H; Huang L; Jia H; Yang X; Zheng M; Sun J; Li J
BMC Cancer; 2022 Jul; 22(1):818. PubMed ID: 35883111
[TBL] [Abstract][Full Text] [Related]
12. Multicenter retrospective analysis of metastatic colorectal cancer (CRC) with high-level microsatellite instability (MSI-H).
Goldstein J; Tran B; Ensor J; Gibbs P; Wong HL; Wong SF; Vilar E; Tie J; Broaddus R; Kopetz S; Desai J; Overman MJ
Ann Oncol; 2014 May; 25(5):1032-8. PubMed ID: 24585723
[TBL] [Abstract][Full Text] [Related]
13. Crosstalk Between the MSI Status and Tumor Microenvironment in Colorectal Cancer.
Lin A; Zhang J; Luo P
Front Immunol; 2020; 11():2039. PubMed ID: 32903444
[TBL] [Abstract][Full Text] [Related]
14. Identifying GNG4 might play an important role in colorectal cancer TMB.
Zhao H; Sheng D; Qian Z; Ye S; Chen J; Tang Z
Cancer Biomark; 2021; 32(4):435-450. PubMed ID: 34275892
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of PIM1 blocks the autophagic flux to sensitize glioblastoma cells to ABT-737-induced apoptosis.
Remy J; Linder B; Weirauch U; Konovalova J; Marschalek R; Aigner A; Kögel D
Biochim Biophys Acta Mol Cell Res; 2019 Feb; 1866(2):175-189. PubMed ID: 30389373
[TBL] [Abstract][Full Text] [Related]
16. Interferon regulatory factor family influences tumor immunity and prognosis of patients with colorectal cancer.
Chen YJ; Luo SN; Dong L; Liu TT; Shen XZ; Zhang NP; Liang L
J Transl Med; 2021 Sep; 19(1):379. PubMed ID: 34488791
[TBL] [Abstract][Full Text] [Related]
17. The Natural Compound Myricetin Effectively Represses the Malignant Progression of Prostate Cancer by Inhibiting PIM1 and Disrupting the PIM1/CXCR4 Interaction.
Ye C; Zhang C; Huang H; Yang B; Xiao G; Kong D; Tian Q; Song Q; Song Y; Tan H; Wang Y; Zhou T; Zi X; Sun Y
Cell Physiol Biochem; 2018; 48(3):1230-1244. PubMed ID: 30045021
[TBL] [Abstract][Full Text] [Related]
18. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
[TBL] [Abstract][Full Text] [Related]
19. Androgen Receptor and
Ntzifa A; Strati A; Koliou GA; Zagouri F; Pectasides D; Pentheroudakis G; Christodoulou C; Gogas H; Magkou C; Petraki C; Kosmidis P; Aravantinos G; Kotoula V; Fountzilas G; Lianidou E
Cancer Genomics Proteomics; 2021; 18(2):147-156. PubMed ID: 33608311
[TBL] [Abstract][Full Text] [Related]
20. Identification and validation of an immune prognostic signature in colorectal cancer.
Li M; Wang H; Li W; Peng Y; Xu F; Shang J; Dong S; Bu L; Wang H; Wei W; Hu Q; Liu L; Zhao Q
Int Immunopharmacol; 2020 Nov; 88():106868. PubMed ID: 32771948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]